SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS (SOPHIE)
Advanced Ovarian Cancer
About this trial
This is an interventional prevention trial for Advanced Ovarian Cancer focused on measuring Prehabilitation, Advanced ovarian cancer, cytoreductive surgery, postoperative complications, exercise training, nutrition, physical activity, mindfulness meditation
Eligibility Criteria
Inclusion Criteria:
- Patients with advanced ovarian cancer subject to primary debulking surgery or interval surgery after 3-4 cycles of chemotherapy or secondary and / or tertiary debulking surgery .
- Patients with Eastern Cooperative Oncology Group (ECOG) performance status 2-0.
- Adherence of at least 75 % of the program or minimum of 6 sessions.
Exclusion Criteria:
- Surgery without a minimum of 3 weeks of prehabilitation time.
- Unstable respiratory or heart disease.
- Locomotor or cognitive limitations that makes not feasible the adherence to the program.
- Refusal of the patient.
Sites / Locations
- Hospital Clinic BarcelonaRecruiting
- Biomedical Research Institute la Fe
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Usual care
Multimodal prehabilitation
Control group will follow the standard preoperative measures "Enhanced Recovery After Surgery" (ERAS®) established in the protocols of our hospital. Standard preoperative measures: recommendation of nutritional and physical activity and advice to stop smoking and reduce alcohol intake; optimization of preoperative pathologies including anaemia. An information document on ERAS® measures in our center will be attached to all of them.
Patients following the standard preoperative policies of our institution and the multimodal prehabilitation program